FBXO47: A Potential Drug Target and Biomarker (G494188)

Target Name: FBXO47

NCBI ID: G494188

FBXO47

Other Name(s): F-box only protein 47 | F-box protein 47 | FBX47_HUMAN

FBXO47: A Potential Drug Target and Biomarker

FBXO47 is a protein that is expressed in various tissues and cells of the human body. Its full name is F-box only protein 47, and it is a member of the F-box protein family, which is a family of proteins that are known for their unique structural features. This protein is of particular interest to researchers because of its potential role as a drug target or biomarker.

Diseases and Therapies

One of the most promising aspects of FBXO47 is its potential as a drug target. FBXO47 has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that FBXO47 is overexpressed in various types of cancer, including breast, lung, and ovarian cancer. Additionally, research has suggested that FBXO47 may be a potential biomarker for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Another potential use of FBXO47 as a drug target is its role in the development of neurodegenerative diseases. FBXO47 has been shown to promote the formation of neurofibrillary tangles, which are a hallmark of neurodegenerative diseases, in mouse models of Alzheimer's disease. This suggests that FBXO47 may be a useful target for therapies that are designed to prevent or reverse the development of these diseases.

Another potential use of FBXO47 as a drug target is its role in autoimmune disorders. FBXO47 has been shown to play a role in the development of autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis. This suggests that FBXO47 may be a useful target for therapies that are designed to treat these disorders.

FBXO47 as a Biomarker

FBXO47 has also been shown to serve as a potential biomarker for a variety of diseases. For example, studies have shown that FBXO47 is overexpressed in various types of cancer, including breast, lung, and ovarian cancer. This suggests that FBXO47 may be a useful biomarker for these diseases, and that it may help doctors to diagnose and monitor the effectiveness of treatments.

In addition to its potential as a biomarker, FBXO47 has also been shown to serve as a potential therapeutic target in cancer. Studies have shown that FBXO47 can inhibit the growth of cancer cells in a variety of settings, including in cell culture and in animal models of cancer. This suggests that FBXO47 may be a useful target for cancer therapies that are designed to inhibit the growth of cancer cells.

Conclusion

In conclusion, FBXO47 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Its unique structural features and its role in the development of various diseases make it an attractive target for researchers to study. Further studies are needed to determine the full potential of FBXO47 as a drug target and biomarker.

Protein Name: F-box Protein 47

Functions: Probably recognizes and binds to some phosphorylated proteins and promotes their ubiquitination and degradation

The "FBXO47 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FBXO47 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets